From a clinical perspective, patients with pathogenic variants in the POLG-gene affecting mitochondrial health may present a wide range of clinical symptoms, ranging from mild muscle weakness to stroke-like episodes and liver failure. This evidence concerns the gene POLG and stroke disorder.